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Background: Tumor grading, PSA concentration, and stage determine a risk of prostate
cancer patients with accuracy of about 70%. An approach based on the fractal
geometrical model was proposed to eliminate subjectivity from the evaluation of tumor
aggressiveness and to improve the prediction. This study was undertaken to validate
classes of equivalence for the spatial distribution of cancer cell nuclei in a larger,
independent set of prostate carcinomas.
Methods: The global fractal capacity D0, information D1 and correlation D2 dimension,
the local fractal dimension (LFD) and the local connected fractal dimension (LCFD),
Shannon entropy H and lacunarity λ were measured using computer algorithms in
digitalized images of both the reference set (n = 60) and the test set (n = 208) of
prostate carcinomas.
Results: Prostate carcinomas were re-stratified into seven classes of equivalence.
The cut-off D0-values 1.5450, 1.5820, 1.6270, 1.6490, 1.6980, 1.7640 defined the
classes from C1 to C7, respectively. The other measures but the D1 failed to define
the same classes of equivalence. The pairs (D0, LFD), (D0, H), (D0, λ), (D1, LFD), (D1,
H), (D1, λ) characterized the spatial distribution of cancer cell nuclei in each class. The
co-application of those measures enabled the subordination of prostate carcinomas
to one out of three clusters associated with different tumor aggressiveness. For D0 <
1.5820, LFD < 1.3, LCFD > 1.5, H < 0.7, and λ > 0.8, the class C1 or C2 contains
low complexity low aggressive carcinomas exclusively. For D0 > 1.6980, LFD > 1.7644,
LCFD > 1.7051, H > 0.9, and λ < 0.7, the class C6 or C7 contains high complexity
high aggressive carcinomas.
Waliszewski Classes of Equivalence and Tumor Aggressiveness
Conclusions: The cut-off D0-values defining the classes of equivalence were validated
in this study. The cluster analysis suggested that the number of the subjective Gleason
grades and the number of the objective classes of equivalence could be decreased from
seven to three without a loss of clinically relevant information. Two novel quantitative
criteria based on the complexity and the diversity measures enabled the identification
of low or high aggressive prostate carcinomas and should be verified in the future
multicenter, randomized studies.
Keywords: fractals, complexity, Renyi dimensions, entropy, lacunarity, tumor aggressiveness, grading, prostate
carcinoma
SYNOPSIS
The spatial distribution of cancer cell nuclei in digitalized
histological images of prostate carcinomas reflects complex
intercellular interactions within malignant tumor underlying
its biological aggressiveness. Since this distribution can be
characterized by a number of complexity and diversity measures,
those measures define the quantitative criteria for low complexity
carcinomas with low aggressiveness or for high complexity
carcinomas with high aggressiveness.
INTRODUCTION
Histological evaluation of tumor aggressiveness, that is a
potential of cancer cells for local growth and metastasis
formation, is a key element in both diagnosis and prognosis
of any malignancy. In the case of prostate carcinomas,
pathologists developed about 40 subjective grading systems
scaling aggressiveness of those tumors (reviewed in Humphrey,
2003). The Gleason system (Gleason, 1977) is the most
commonly used one (Humphrey, 2004). It was validated with
a database of a few thousand prostate cancer patients. Since its
revision in 2005 and in 2010, the Gleason system comprises three
patterns of tumor growth called the Gleason grades (Epstein
et al., 2005; Epstein, 2010). The Gleason score is calculated as
a sum of two or, sometimes, three Gleason grades representing
most predominant patterns of growth in a given carcinoma.
This information co-determines the risk stratification of cancer
patients. According to that stratification, cancer patients will
undergo follow-up or will be treated. That latter option comprises
a choice of the optimal therapy, extent of surgical resection with
or without nerve sparing or dosing of radiation therapy (Epstein
et al., 2005; Epstein, 2010; Lotan and Epstein, 2010).
A prostate biopsy is a procedure to obtain small samples
of prostate tissue for the microscopic examination using a
thin needle. Owing to both the limitations in obtaining a
representative tissue specimen and a low specificity of this
procedure, there is no good correlation between the grading score
of the prostate carcinomas in biopsy tissues and in prostatectomy
specimen (Fine et al., 2012). Using a prostate biopsy, one cannot
predict the existence of insignificant (indolent) cancer, that is
cancer without a significant influence on survival (Epstein et al.,
1994), the final histological grade, size of tumor, its extracapsular
extension, the existence of positive margins or lymph node
involvement (D’Amico et al., 2000; Boccon-Gibod et al., 2005;
Fine et al., 2012). In addition, the modification of the criteria
in the Gleason system (Epstein et al., 2005; Epstein, 2010)
caused both a discrepancy in tumor grading and difficulties in
comparison of treatment results for patients treated before and
after the change (Lotan and Epstein, 2010). Although tumor
aggressiveness is a key parameter in the prediction models,
the subjectivity of histological evaluation is a source of the
prediction weakness. Human eye is not able to evaluate correctly
many details in tumor images, such as the ratio of cells bound
in glands to the number of infiltrating cancer cells, or some
configurations, such as the co-existence of glands of different
size and shape. It is a challenge for pathologists to match the
images to the definition of a grade, especially in the borderline
cases (reviewed in Montironi et al., 2013). The subjective tumor
grading has a significant inter- and intraobserver variability
in the range of 38–80% (Nguyen et al., 2004; van der Kwast
et al., 2010; McKenney et al., 2011; Netto et al., 2011; Egevad
et al., 2013; Berney et al., 2014) and the coefficient κ for
interobserver agreement 0.15–0.7 (McLean et al., 1997; Allsbrook
et al., 2001; van der Kwast et al., 2010; McKenney et al., 2011;
Scott Lucia et al., 2013). Even though some DNA-, RNA-, or
protein biomarkers were co-applied, it did not improve the
accuracy of grading. The value of the correlation coefficient was
low in the range of 0.1–0.6 (McDunn et al., 2013; Pin et al., 2013).
A novel diagnostic tool, prostate magnetic resonance imaging
reinforced by the multiwavelet filters was supposed to enable the
automated diagnosis of prostate carcinoma. The results remain
nonspecific. Biopsies must be performed to evaluate tumor
aggressiveness nonetheless (reviewed in Turkbey and Choyke,
2012).
A decision whether a prostate cancer patient should be
treated or not depends on the fulfillment of two criteria [Klein,
2014; Mottet et al., 2015; National Comprehensive Cancer
Network (NCCN), 2015]. The first one is the patient’s overall life
expectancy determined by age, health status, and comorbidities.
In particular, patients older than 75 years, with life expectancy
less than 10 years, in a reduced health status or with serious
comorbidities will not be treated with the intention to cure.
This category of patients will be offered a program of watchful
waiting with a follow-up schedule. A palliative treatment can be
initiated if local or metastatic progression with clinical symptoms
occurs. The second criterion plays a pivotal role in the risk
assessment of cancer progression. It considers three parameters
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(Partin et al., 1997), such as biological aggressiveness of tumor
described by the subjective tumor grading according to Gleason
(Gleason, 1977; Humphrey, 2003, 2004; Epstein et al., 2005;
Epstein, 2010), PSA concentration in serum (Stamey et al., 1989;
D’Amico et al., 2004, 2005; Thompson et al., 2006; ElShafei et al.,
2013; Wu et al., 2014), and tumor stage (Prout et al., 1980; Petros
and Catalona, 1992). The statistical accuracy of the nomograms
based on those parameters approximates 70% only (Partin et al.,
1997; Miller et al., 2006; Thompson et al., 2006; Klotz et al.,
2010).
According to the clinical guidelines [Klein, 2014; Mottet
et al., 2015; National Comprehensive Cancer Network (NCCN),
2015], low risk cancer patients with PSA < 10 ng/ml, Gleason
score of 6 or less, and pT1-2a stage do not need any
treatment, nor an adjuvant therapy. Despite of those criteria,
the overtreatment occurs at the indolent stadium of the disease
in about 55% of patients (Miller et al., 2006; Danzig and
McKiernan, 2014; Daskivich et al., 2014). Urologists recommend
frequently treatment even for 80-year-old patients with limited
life expectancy (Dall’Era et al., 2008; Albertsen, 2010; Danzig and
McKiernan, 2014; Daskivich et al., 2014). Rather, those patients
should be followed-up to identify local tumor progression and
aggressive metastatic disease in the long term (Klotz, 2006;
Denis, 2007; Dall’Era et al., 2008; Albertsen, 2010); phenomena
especially frequent about 15 years from the diagnosis (Albertsen
et al., 2005; Cooperberg et al., 2011; Cooperberg, 2015; Klotz et al.,
2014). The same strategy might also be offered to some patients
with intermediate risk of progression (PSA 10–20 ng/ml, Gleason
score 7, pT2b-2c) (Cooperberg et al., 2011). Unfortunately,
only up to 49% of eligible patients participate in the follow-up
programs (Womble et al., 2015). The lack of the histological,
molecular or clinical criteria for the unequivocal identification
of the low risk cancer patients increases a fear for tumor
progression among those involved in active surveillance as well
as among those who already underwent some kind of aggressive
therapy, without even knowing if they needed it (Womble et al.,
2015).
Patients with high-risk (PSA >20 ng/ml, Gleason score 8–
10, stage T3a) or very high risk carcinomas (stage T3b–T4 N0
or any T N1) should be treated aggressively with all available
modalities, such as surgery, radiotherapy, brachytherapy, or
hormonal therapy, even though a choice of a modality seems to
increase survival in about 10% of patients (Heidenreich et al.,
2014). For example, SEER, a population-based cohort study of
66,717 patients 66 years of age or older with localized prostate
cancer demonstrated that primary hormonal therapy did not
improve long-term overall or disease-specific survival (Lu-Yao
et al., 2014).
The relevant question, whether a given prostate carcinoma
is an indolent, low grade, low risk malignancy rather than a
high grade, high risk one can be answered only if prostate gland
is removed surgically. Although this answer appears after the
initiation of the aggressive treatment, it is still important to
get the unequivocal evaluation of tumor aggressiveness based
on some objective, quantitative criteria. Those criteria might
help to improve the accuracy of prognosis, to plan more
individualized therapy, or to facilitate a search for some features
of cancer cells that would improve predictions made on the
basis of biopsies. A variety of approaches, such as graph models
(Altunbay et al., 2010), gland segmentation with morphometric
analysis and application of probabilistic pairwise Markov models
(Naik et al., 2008; Loeﬄer et al., 2012; Nguyen et al., 2012),
color channel histograms, texture analysis, fractal algorithm
with fractal code or multifeature analysis with a number of
classifiers, such as Bayesian one (Doyle et al., 2007), multiwavelet
method (Jafari-Khouzani and Soltanian-Zadeh, 2003; Candes
et al., 2006; Huang and Lee, 2009; Hong-Jun et al., 2011; Veltri
et al., 2012; Lopez and Again, 2013), k-NN one (Tabesh et al.,
2005), support vector machine (Tabesh et al., 2007), or linear
discriminant analysis method (Tabesh et al., 2005, 2007) were
proposed for the automated diagnosis of prostate carcinoma or
for the evaluation of tumor aggressiveness. Those statistically
elegant and mathematically advanced approaches resulted in
the maximal accuracy of 78–81% for grading in the case of
multiwavelet method (Tabesh et al., 2005, 2007). The accuracy
of 95–97% was reported only for the low number of carcinomas
(Lopez and Again, 2013). This discrepancy between the Gleason
grading and the quantitative classifications generated by the
sophisticated computer algorithms had at least one reason. Two
different categories of data, the subjective and the objective one,
should not be compared each other if the subjective tumor
grading according to Gleason is chosen as the absolute frame of
reference.
Since, there is no golden standard in pathology of
adenocarcinomas that might be used as the objective frame
of reference for the quantitative studies, a novel approach based
on the fractal geometric model of prostate carcinomas and
evaluation of complexity in the spatial distribution of cancer
cell nuclei was proposed (Waliszewski, 2013; Waliszewski
et al., 2014, 2015). Cell nuclei are fragments of the surface in
two-dimensional histological images. They compose irregular,
yet self-affine configurations (Waliszewski, 2013). The fractal
geometrical model of prostate carcinomas introduced the idea
of the distinct classes of equivalence called complexity classes
(Waliszewski et al., 2015). Those classes were defined by the
values of the global capacity fractal dimension D0. Using that
model, all basic patterns of growth seen in prostate cancer
were subordinated to the appropriate class. In particular,
low grade prostate carcinomas with well-preserved glandular
structure were re-stratified to the class C1, C2, or C3. High
grade carcinomas with the predominating infiltrating patterns of
growth were stratified to the class C6 or C7.
This study was undertaken to validate the classes of
equivalence (Waliszewski et al., 2015) using utterly novel set
of carcinomas than that used in the study (Waliszewski, 2013;
Waliszewski et al., 2014, 2015). A question arises whether
the additional complexity or diversity measures, such as
the local fractal dimensions, Shannon entropy or lacunarity
allow a similar stratification of prostate carcinomas into the
same classes of equivalence? Is it possible to define some
quantitative criteria based on all those parameters that define
prostate carcinomas with low or high complexity of the spatial
distribution of cancer cell nuclei associated with low or high
tumor aggressiveness?
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METHODS
The Renyi Family of the Global Fractal
Dimensions
The Renyi family of the global spatial fractal dimensions
comprises the capacity (D0), information (D1), and correlation
(D2) dimension. The appropriate introduction to the theory of
dimension, fractals, or the formal mathematical definitions of
the fractal dimensions can be found elsewhere (Engelking, 1978;
Czyz, 1994). Briefly, the capacity dimension D0 is defined as a
relationship between the logarithm of a number of boxes N(ε)
covering the geometric object and the logarithm of a box size ε
(Equation 1; Vicsek, 1992; Kinsner, 2007):
D0 = lim
ε→0
logN(ε)
log 1
ε
(1)
The information dimension D1 measures how the average
information needed to identify an occupied box, scales, as the
scale of boxes gets smaller. The algorithm for the information
dimension will search for the linear relationship between the
logarithm of a box size (ε) and the logarithm of the probability
p that a given box contains the element of the object (Equation 2;
Baker and Gollub, 1996).
D1 = lim
ε→0
−〈log pε〉
log 1
ε
(2)
The correlation dimension D2 measures the number of pointsM
used to generate a representation of the fractal and the number
of pairs of points closer than ε to each other. The correlation
dimension is a probability measure that two pixels within the
object are close to each other less than ε. The appropriate
algorithm calculates not only if a given box is occupied by the
pixel of the analyzed geometric object, but also how many pixels
in the box are, and how close to each other they are (Equation 3):
D2 = lim
ε→0,M→∞
log(gε
/
M2
)
log ε
(3)
in whichM is a number of pixels of the analyzed geometric object
and gε denotes a number of pairs of pixels that are closer to each
other than ε (Grassberger and Proccacia, 1983; Baker and Gollub,
1996).
Local Connected Fractal Dimension
The local fractal dimension (LFD) is the fractal capacity
dimension calculated according to Equation 1 for every pixel
in the image. This dimension is a local and indirect measure of
intercellular connectivity, i.e., interconnectedness which denotes
the existence of complex, dynamic relationships in a population
of cells leading to the spatial and temporal emergence of global
features in the system that would never appear in a single
cell existing out of the system (Waliszewski, 1997, 2005, 2009;
Waliszewski et al., 1998, 2001; Waliszewski and Konarski, 2001).
The local connected fractal dimension (LCFD) characterizes
local irregularities of geometry of heterogeneous geometrical
objects, such as clusters of cancer cells present either in glands
or in infiltrates. Instead of a single value of the global fractal
capacity dimension D0 calculated for the entire image, one gets
a set of values calculated for each pixel that belongs to the
analyzed object. This is done according to the following Image
J algorithm:
Step 1: choose a pixel P that belongs to the analyzed object and
possesses eight neighbor pixels.
Step 2: define the local connected set of pixels by finding all
the pixels connected to the pixel P within the increasing
s-pixel-side window centered at P.
Step 3: count how many pixels N(s) of the analyzed object are
within the window.
Step 4: use the least square method to compute the slope of the
log-log curve composed by the coordinates [log(N(s),
log(s); Landini et al., 1995].
Entropy and the Global Information Fractal
Dimension D1
The Shannon entropy H is a statistical measure of both the
information content and diversity in a given cell configuration
in the image. It can be used to characterize gray images or
binary images of the spatial distribution of cancer cell nuclei. The
Shannon entropy describes the following Equation (4):
H = −
∑
i
pi log2 pi (4)
In the above equation, pi denotes the probability that the
difference between two adjacent pixels of the image is equal to i,
and is calculated from the histogram counts. Low entropy images,
such as those containing mostly black background, e.g., in benign
prostatic hyperplasia or in well-differentiated adenocarcinomas,
have large numbers of pixels with the same zero value. The black
image that contains no white pixels will have entropy equal zero.
The entropy HD of a set with D dimensions is defined by the
following Equation (5):
HD = −
∑
i
pi log2 pi + Dlog ε = H + Dlogε (5)
ín which H stands for the Shannon entropy (see Equation 4), ε
denotes size. In consequence, entropyH is a linear function of log
ε with slope D and intersection HD. It is important to notice that
the slope D in the limit for ε = 0 becomes the global information
fractal dimension D1 (see Equation 2; Sethna, 2011).
Lacunarity
Cancer cells form various morphological patterns. The areas of
the image complementary to the lumen of glands correspond to
the gaps on the binary image. Investigating those gaps provides
important information about homogeneity of cell distribution in
malignant tumor. Lacunarity λ, that is, a degree of gappiness,
inhomogeneity, or translational and rotational invariance in
the image characterizes quantitatively those gaps as well as
differences in their spatial distribution between the patterns of
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growth. This parameter can also quantify differences between
self-similar structures having the same global fractal dimension
(Plotnick et al., 1996).
In general, lacunarity λ is equivalent to the square of the
coefficient of variation, CV, and expresses a relationship between
standard deviation σ and mean µ for the pixels in a given area of
an image, and a number of pairs of pixels g that are closer to each
other than ε:
λǫ,g = (CVǫ,g)
2
= (
σǫ,g
µǫ,g
)
2
(6)
More specifically, lacunarity λ is a relationship between variation
for the function P(m, r), that defines probability of the
localization of the pixels m in the square of size r to the square
of the mean value of that function (Equation 7):
λ(r) =
∑r2
m=1m
2P(m, r)−
(∑r2
m=1mP(m, r)
)2
(∑r2
m=1mP(m, r)
)2 (7)
The computer algorithms that calculate the mean value of
lacunarity for images use the same principle as in the case of
the global fractal dimensions, i.e., they analyze the digital image
from different scaled levels of resolution to examine how certain
geometric features change with the size of the element used to
inspect the image. The first approach, called box counting, is
identical with the principle underlying the capacity dimension
(see above) in the sense that the box for each ε is placed as
though it were part of a grid overlaid on the image so that the
box does not overlap itself. In the second one, called the sliding
box algorithm, the box is slid over the image so that it overlaps
itself and the sliding box lacunarity is calculated. The values
are usually expressed as logarithms. Lacunarity analyses using
the types of values discussed above have shown that data sets
extracted from geometric fractals, or from patterns that change
little when rotated have low lacunarity. The larger and more
irregular are the gaps in the image, as those seen in glands in
benign prostatic hyperplasia, the greater is the value of lacunarity.
In some instances, fractal dimensions and values of lacunarity can
be correlated, but it does not hold for all types of patterns and
measures of lacunarity.
Patients, Preparation of Images, and
Isolation of Cell Nuclei
This study was performed according to the ethical standards
outlined in the WMA Declaration of Helsinki “Ethical Principles
for Medical Research Involving Human Subjects” (http://www.
wma.net). The data bankwas constructed and analyzed according
to the ethical requirements of the Ethics Committee for the
Medical Faculty of the Justus-Liebig University in Giessen,
Germany (ethical vote 49/05). Since this project was based solely
on computer-aided image analysis of the digitalized anonymous
tissue slides of prostate carcinomas, no written consent from the
prostate cancer patients was necessary. The surgical procedures
were performed from 2007 to 2010. Tissues were stained with
hematoxylin and eosin as well as with the appropriate antibodies
against the markers, i.e., PSA (DAKO, Germany) and AMACR
(DAKO, Germany) for prostate cancer cells, cytokeratin 34βE12
(Leica Biosystems, Canada) for basal cells in order to confirm the
diagnosis (Kristiansen and Epstein, 2014), and classified by the
Gleason criteria (Gleason, 1977; Humphrey, 2003, 2004; Epstein
et al., 2005; Epstein, 2010).
A reference set of prostate carcinomas comprised cases
representing the homogeneous patterns with the Gleason score
3 + 3 = 6 defined as a regular gland architecture with no basal
cells and no areas of cellular infiltration (n = 20), the Gleason
score 4+ 4 = 8 defined as dominating small glands spread freely
in the prostate tissue or organized in the cords (n = 20), and
the Gleason score 5+ 5 = 10 defined as a random infiltration of
the prostate tissue by cancer cells without any glands (n = 20),
and benign prostatic hyperplasia (n = 10). We analyzed and
re-stratified a test set of prostate carcinomas comprising 208
carcinomas with the following Gleason score: 3+3 = 6 (n = 70),
3 + 4 = 7a (n = 18), 4 + 3 = 7b (n = 14), 4 + 4 = 8 (n = 23),
4+5 = 9 (n = 28), 5+4 = 9 (n = 20), 5+5 (n = 35). All prostate
carcinomas were subordinated to the appropriate subsets called
structural Gleason classes using the Gleason criteria. We also
analyzed benign prostatic hyperplasia (n = 20). None of the
patients had lymphatic or distant metastases.
Histological slides of prostate carcinomas stained with
hematoxylin and eosin were digitalized using both a microscope
Axioskop 5.0 with the halogen lamp 12V 50W 2800K 950 lm
and the objective Plan Neofluar 20x with the numerical aperture
0.5, Zeiss, Germany and a camera Nikon Coolscope, Japan.
The optimal conditions for the magnification (20x) and lighting
intensity (41.19× 106 lx) were chosen in such a manner that the
values of the capacity fractal dimension for the test image were in
the plateau-area of the test curve (data not shown).
The color images in the bmp format with 1240 × 1000 pixels
and resolution 150 × 150 dpi were first resized to the jpg
format with 648 × 432 pixels and resolution 150 × 150 dpi.
Cancer cell nuclei were isolated electronically using a package
Definiens Tissue Map ver. 7.0 (Definiens, Munich, Germany),
and stored as RPG images in the jpg format with 648 × 432
pixels, resolution 150 × 150 dpi. Both conversion to the eight-
bit images and their thresholding to the binary images, i.e.,
images having only 0 (black) and 255 (white) pixel values
was performed using the Renyi Entropy filter of the open-
source software Image J ver 1.48v (NIH, Bethesda, USA, http://
imagej.nih.gov/ij/). The images were analyzed by the computer
algorithms measuring the global fractal dimensions of the Renyi
family, i.e. capacity dimension D0 and information dimension
D1 (Benoit 1.3, True Soft, USA, http://www.trusoft-international.
com/benoit.html), and correlation dimension D2 (Fractalyse
2.4, CNRS Universite de Franche-Comte, France, http://www.
fractalyse.org). The values of the global fractal dimensions
generated by the computer algorithms were verified against the
geometrical model (Waliszewski, 2013; Waliszewski et al., 2014,
2015). Both the local fractal dimension and the local connected
fractal dimension were measured in the same digitalized images
using the open-source software Image J ver 1.48v and open-
source plugin FracLac 2013 Janb420 by A. Karperien (http://
imagej.nih.gov/ij/plugins).
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Statistical Analysis
The statistical analysis including the ROC analysis was performed
by Sigma Plot ver. 10.0 (Systat Software Inc., San Jose, USA,
http://www.sigmaplot.com). The cluster analysis was performed
by Mathematica ver. 10.0 (Wolfram Research Inc., USA) and
Statistica ver. 8.0 (Statsoft, Oklahoma City, USA). The following
aspects are important while analyzing a ROC curve. The ROC
curve is a two dimensional graph. It represents a relationship
between sensitivity of a statistical test (y−axis) in a function
of 1–specificity of that test (x−axis). Sensitivity is defined as a
rate of true positive events. The second quantity represents a
rate of non-events that were falsely identified as positive events
for the different cut-off values of a binary classifier, such as D0,
D1, or D2, LFD, etc. Second, the closer the ROC curve follows
the y-axis, and then the top border of the ROC diagram, the
more accurate the statistical test. The area under the ROC curve
(AUC) is a probability of the test accuracy, i.e., a probability
that the classifier discriminates between the elements of two
sets correctly. In particular, the AUC of 1.0 denotes a perfect
relationship between the data that belong to a given category and
those that do not. Third, the closer the ROC curve comes to the
diagonal of the ROC diagram, the AUC is closer 0.5, what denotes
that the test is not able to discriminate between two sets of data.
It should be noted that a task of the re-stratification of prostate
carcinomas on the basis of the quantitative characteristics of the
spatial distribution of cancer cell nuclei by the fractal dimensions
D0,D1, andD2 into the complexity classes is equivalent to the task
of the identification the cut-off values of the best classifier, i.e., the
classifier generating the AUC of 1.0 (Hill and Lewicki, 2006).
Cluster analysis is a data mining tool that uses a number of
computer algorithms and statistical methods to sort elements
of a set into groups (clusters) in such a manner that the
elements belonging to the same cluster have a maximal degree
of association and a minimal degree otherwise. In this work, a
v-fold cross-validation algorithm was applied to determine the
number of clusters in the data. Then, the k-means algorithm
was applied to produce exactly k different clusters predicted
by the first algorithm with the greatest possible distinction and
maximal distances between those clusters. One examines here
the means for each cluster on each dimension (parameter)
to assess how distinct the k-means clusters are. Ideally, the
means for all dimensions should be different, and the magnitude
of the F-values from the analysis of variance performed on
each dimension indicates how well the dimensions discriminate
between clusters (Hill and Lewicki, 2006).
RESULTS
The Global Capacity Fractal Dimension
(D0) and the Information Fractal Dimension
(D1) Discriminate Well between the
Structural Gleason Classes (grades)
Both the global capacity and information fractal dimension,
D0 and D1, have the sufficient statistical power to discriminate
between the Gleason classes, that is the subsets of prostate
carcinomas with the Gleason score 3+3, 4+4, or 5+5. Figures 1,
2 demonstrate that the dimension D0 was slightly better than
FIGURE 1 | The ROC analysis of prostate carcinomas with Gleason
score 3+ 3,4+ 4, and 5+ 5 of the test set demonstrating a
discriminating power of the fractal dimensions D0, D1, and D2. AUC
stands for the area under the curve, and has values in a similar range as in the
case of the reference set.
the dimension D1 (Figure 1) and much better than the global
correlation fractal dimension D2. In that latter case, the area
under the curve (AUC) was almost 1.00 for the dimension D0 vs.
0.8 for the dimension D2. In addition, coefficient of correlation
between the D0 and D1 was very high R = 0.963. The local
fractal dimension, LFD, its variance, the local connected fractal
dimension, LCFD, its variance, entropy H, and lacunarity λ were
not able to discriminate between those classes at the statistically
significant level (data not shown).
It is worth to notice that none of the complexity or
the diversity measures can discriminate between the spatial
distribution of cell nuclei in benign prostatic hyperplasia and
in prostate carcinomas of the complexity class C1 containing
carcinomas with the Gleason score 3+3 (compareTables 1, 3, and
Figure 2). The mean values overlap (Table 3), and differences
between those two groups of tissues are not statistically
significant (t-Student test, p > 0.1).
The Gleason Classes and Complexity
Classes are not Identical
Table 1 contains results of ROC analysis for two sets of prostate
carcinomas. The first one is a reference set. It contains carefully
selected carcinomas with relatively homogeneous structure.
Those carcinomas were stratified into three distinct structural
classes with the Gleason score 3+3, 4+4, or 5+5. The spatial
distribution of cancer cell nuclei in those carcinomas was also
characterized quantitatively by the global fractal dimensions D0,
D1, and D2. The ROC analysis enabled calculation of the cut-off
D0-values that defined the numerical limits of those structural
Gleason classes (see Table 1). As it turned out, even very careful
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TABLE 1 | Results of ROC analysis for the reference set (A) or the test set (B) of prostate carcinomas and their stratification into the structural Gleason
classes.
Gleason classes Sensitivity Specificity Cut off-value D0 AUC p-value
(A) REFERENCE SET
BPH vs. Gleason 3+ 3 0.50 0.40 1.5050 0.48 1.10
Gleason 3+ 3 vs. 4+ 4 1.00 1.00 1.6040 1.00 <0.0001
Gleason 4+ 4 vs. 5+ 5 1.00 1.00 1.6910 1.00 <0.0001
(B) TEST SET
BPH vs. Gleason 3+3 0.50 0.51 1.5130 0.50 0.96
Gleason 3+3 vs. 3+4 0.63 0.67 1.5290 0.64 <0.09
Gleason 3+4 vs. 4+3 0.78 0.67 1.5580 0.79 0.008
Gleason 4+3 vs. 4+4 0.75 0.78 1.6160 0.85 0.0008
Gleason 4+4 vs. 4+5 0.56 0.50 1.6400 0.47 1.27
Gleason 4+5 vs. 5+4 0.86 0.70 1.6870 0.84 <0.0001
Gleason 5+4 vs. 5+5 0.80 0.66 1.7610 0.83 <0.0001
BPH stands for benign prostatic hyperplasia. Data for benign prostatic hyperplasia cases were added to demonstrate that the approach excludes the automated diagnosis of prostate
carcinoma. AUC denotes the area under the curve in the ROC analysis performed at a given p-value. Please, note that the set used in this study was larger and independent of the set
used in the previous analysis (Waliszewski et al., 2015).
FIGURE 2 | The ROC analysis of carcinomas with Gleason score 3+ 3,
4+ 4, and 5+ 5 of the test set demonstrating a discriminating power of
the local fractal dimensions LFD. AUC stands for the area under the curve,
and has values in a similar range as in the case of the reference set.
histological evaluation of tumor structure brought together cases
with a variety of infinitesimal structural alterations that could
not be defined unambiguously. In consequence, each structural
Gleason class of the reference set contained a low number of
carcinomas with the quantitative characteristic typical of the
other classes. Those cases were re-stratified using the cut-off D0-
values for the structural Gleason classes as a frame of reference.
After that operation, the new cut-off D0-values were calculated.
They define the complexity classes C1, C4, and C7 (compare
Table 1A with Table 2A).
The Cut-off D0-values of the Structural
Gleason Classes 3+4, 4+3, 4+5, or 5+4 are
Located between the Values for the
Structural Gleason Classes 3+3, 4+4, or
5+5
The test set contains prostate carcinomas representing all
Gleason scores. Those carcinomas were chosen randomly from
the archive (Table 1B). The cut-off D0-values for the structural
classes Gleason 3+3, 4+4, or 5+5 in that set are close to those
of the reference set if analyzed without the structural classes
3+4, 4+3, 4+5, and 5+4. The same is true of the AUC values
(Figures 1, 2) as well as sensitivity and specificity (data not
shown). It appears that human eye deals much better with the
evaluation of the distinct homogeneous structures rather than
with the heterogeneous ones, where the number of details is
greater, more difficult to grasp, and to set in order.
If the structural classes 3+4, 4+3, 4+5, and 5+4 are taken
into consideration, the cut-off D0-values locate them between
the values for the structural classes Gleason 3+3, 4+4, or 5+5.
TheD0 intervals defining those heterogeneous classes are smaller
now (compare with Tables 1A,B). However, both sensitivity
and specificity are not equal 1.00. The AUC values are also
far from 1.0. This is because all structural classes of the test
set including those with seemingly homogeneous carcinomas
contain some number of cases with complexity measures typical
of the other structural Gleason classes. As expected, those
“impure” cases were re-stratified according to the D0-cut-off
values, as described in the next paragraph, to the adjacent
complexity classes exclusively.
Re-Stratification of Prostate Carcinomas
into the Seven Classes of Equivalence
Re-stratification puts aside a problem of accuracy of the
subjective evaluation as well as troubles connected with a
matching of tumor structure under examination to the grade
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TABLE 2 | Results of the ROC analysis for the re-stratified reference set (A) or the re-stratified test set (B) of prostate carcinomas.
Complexity classes Sensitivity Specificity Cut off-value D0 AUC p-value
(A) REFERENCE SET
C1 vs. C4 1.00 1.00 1.5980 1.00 <0.0001
C4 vs. C7 1.00 1.00 1.7000 1.00 <0.0001
(B) TEST SET
C1 vs. C2 1.00 1.00 1.5450 1.00 <0.0001
C2 vs. C3 1.00 1.00 1.5820 1.00 <0.0001
C3 vs. C4 1.00 1.00 1.6270 1.00 <0.0001
C4 vs. C5 1.00 1.00 1.6490 1.00 <0.0001
C5 vs. C6 1.00 1.00 1.6980 1.00 <0.0001
C6 vs. C7 1.00 1.00 1.7640 1.00 <0.0001
The cut-off D0-values define the seven classes of complexity. Those classes of equivalence contain prostate carcinomas with the D0-values within the expected interval ranges as
previously reported (Waliszewski et al., 2015). The complexity classes overlap to some extent with the structural Gleason classes. The average discrepancy in this study approximates
53%. AUC denotes the area under the curve in the ROC analysis performed at a given p-value. Please, note that the set used in this study was larger and independent of the set used
in the previous analysis (Waliszewski et al., 2015).
definition. This was achieved by the application of the cut-
off D0-values of the re-stratified reference set (see Table 2A).
Carcinomas with the quantitative characteristics that did not
match well the characteristics of the other carcinomas of the same
class, nor of the adjacent class were identified and clustered in
the novel classes of equivalence defined by the novel D0-values.
As a result, carcinomas of the test set were re-stratified to the
seven classes of complexity, i.e., C1, C2, C3, C4, C5, C6, and
C7 (Table 2B). Table 3 provides a percentage of cases of each
structural Gleason class that was a subject to re-stratification.
This was from 30 to 70% of cases per structural class.
It should be emphasized that all complexity classes are
unequivocally defined by the cut-off D0-values. Therefore, the
complexity classes contain only those prostate carcinomas that
have the spatial distribution of cancer cell nuclei characterized
by the similar values of the dimension D0 and hold a condition
that the AUC in the ROC analysis equals 1.0. As expected,
an identical re-stratification can be obtained with D1-values
(compare Figure 3B). Each complexity class contains elements of
the corresponding structural Gleason class and some carcinomas
of the other structural Gleason classes with the D0-values within
the range for that class. For example, Figure 3A presents each
carcinoma of the test set as a point on the 2D-scatter plot with
the D0 and the LFD as variables. Each carcinoma belongs to one
out of seven classes of equivalence according to the D0-values.
Table 3 shows the statistically significant differences between all
complexity classes for the D0, and the D1 (p < 0.0001, t-Student
test). This finding confirms a choice of the cut-offD0 orD1-values
as a criterion for the re-stratification.
A Relationship between the Global
Capacity Dimension D0 and Lacunarity λ or
the Global Information Dimension D1 and
Entropy H or is Linear
The relationship between theD0 and λ is given by linear equation
(8):
λ = 2.0701− 0.8145D0 (8)
The coefficient of correlation R for that relationship was -0.902.
As it can be seen in Figure 3C, a given value of lacunarity λ
may be associated with different values of the D0 dimension and
different corresponding spatial distributions of cancer cell nuclei
that belong to the neighbor classes of equivalence. Hence, the
λ value is not a good classifier. However, if this parameter is
coupled with theD0-value, it characterizes the spatial distribution
of cancer cell nuclei unequivocally.
A similar capability possesses a pair (D1, H). As expected,
there was a linear relationship between the global information
fractal dimension D1 and entropy H given by the following
statistical equation (9)
H = −1.4280+ 1.3511D1 (9)
Figure 3B demonstrates a distribution of carcinomas around
the linear curve defined by Equation (9). The coefficient
of correlation R for that relationship was 0.950. The linear
relationship between the global information dimension as a
complexity measure of cell nuclei clustering and the Shannon
entropy as a diversity measure of information content validates in
the independent manner the choice of the classes of equivalence.
The D1 is more accurate classifier than the Shannon entropy H
(Figure 3B). Some carcinomas of the class C3, C4, C5, C6, or
C7 have entropy values that overlap with the values of the cases
belonging to the adjacent classes. In particular, carcinomas of the
class C7 are composed of cellular infiltrates only. Some of them
have, however, a much lower number of infiltrating cells. Entropy
of those carcinomas is lower, respectively (see Figure 3B, Class
C7, light blue diamond). The values of lacunarity for those cases
overlap with those for carcinomas of the class C5 (seeTable 3 and
Figure 3D).
A statistical relationship between lacunarity λ and the
Shannon entropy H is more complex. This relationship is
described by three linear equations that are defined for different
intervalls of the H-values. The first one is given by equation (10)
λ = 1.0301− 0.3057H (10)
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TABLE 3 | The values of the mean, median and standard deviations for the complexity or diversity measures in the re-stratified test set of prostate
carcinomas.
Staging Grading
PSA ng/ml
pT1b - pT2a
Gleason 6
PSA < 10
pT2b-pT2cGleason 7-810 < PSA < 20 pT3a-pT3bGleason 9-10PSA > 20
Gleason Class GS 3+3 GS 3+4 GS 4+3 GS 4+4 GS 4+5 GS 5+4 GS 5+5
n = 70 n = 18 n = 14 n = 23 n = 28 n = 20 n = 35
Complexity/Diversity
Measures
BPH Class C1 Class C2 Class C3 Class C4 Class C5 Class C6 Class C7
n = 20 n = 60 n = 20 n = 37 n = 16 n = 23 n = 29 n = 23
D0 Mean 1.5038 1.4836 1.5659 1.6035 1.6383 1.6684 1.7318 1.7986
Median 1.5154 1.4895 1.5665 1.6023 1.6378 1.6660 1.7287 1.7944
SD 0.0902 0.0490 0.0125 0.0125 0.0066 0.0138 0.0199 0.0241
D1 Mean 1.5222 1.5114 1.5673 1.6081 1.6474 1.6703 1.7282 1.7651
Median 1.5321 1.5190 1.5700 1.6029 1.6403 1.6620 1.7286 1.7570
SD 0.0936 0.0445 0.0250 0.0247 0.0232 0.0260 0.0221 0.0237
D2 Mean 1.5342 1.5525 1.6426 1.6657 1.7046 1.7069 1.7575 1.8107
Median 1.5488 1.5640 1.6466 1.6687 1.6964 1.7144 1.7625 1.7993
SD 0.0734 0.0977 0.0634 0.0586 0.0641 0.0511 0.0357 0.0452
LFD Mean 1.6310 1.5109 1.5396 1.6529 1.6992 1.6897 1.7644 1.8225
Median 1.6310 1.5564 1.5751 1.6492 1.6946 1.6998 1.7716 1.7989
SD 0.0792 0.1447 0.2129 0.1497 0.1342 0.1236 0.0821 0.0552
CV Mean 0.0939 0.0631 0.0582 0.0594 0.0761 0.0817 0.0780 0.0450
LFD Median 0.0829 0.0677 0.0370 0.0466 0.0580 0.0629 0.0696 0.0450
SD 0.0357 0.0253 0.0507 0.0453 0.0522 0.0502 0.0356 0.0144
LCFD Mean 1.4507 1.4908 1.5716 1.6106 1.5663 1.6310 1.7051 1.7212
Median 1.5223 1.5256 1.5625 1.6351 1.5815 1.6401 1.7369 1.7348
SD 0.2063 0.1353 0.1665 0.2110 0.2639 0.1935 0.1313 0.1432
CV Mean 0.1916 0.1403 0.1421 0.1074 0.1462 0.1002 0.1085 0.1154
LCFD Median 0.1724 0.1261 0.1037 0.0973 0.1664 0.0944 0.0898 0.1178
SD 0.0514 0.0473 0.0526 0.0671 0.0831 0.0687 0.0543 0.0609
H Mean 0.5760 0.5638 0.6946 0.7594 0.7866 0.8457 0.9361 0.9500
Median 0.5775 0.5803 0.7007 0.7504 0.7944 0.8451 0.9369 0.9861
SD 0.1234 0.1072 0.0376 0.0337 0.0533 0.0219 0.0253 0.0661
λ Mean 0.8516 0.8597 0.8125 0.7656 0.7527 0.7205 0.6284 0.6108
Median 0.8515 0.8552 0.8141 0.7661 0.7507 0.7210 0.6095 0.5678
SD 0.0524 0.0370 0.0215 0.0309 0.0367 0.0183 0.0405 0.0843
D0 denotes the global capacity fractal dimension, D1 stands for the global information fractal dimension, D2 is the global correlation fractal dimension, LFD is the local fractal dimension,
LCFD is the local connected fractal dimension, CV-LFD stands for the LFD variation, CV-LCFD stands for the LCFD variance, H is the Shannon entropy, λ is lacunarity. The gray color
denotes the existence of statistically significant differences between the complexity classes at p < 0.0001, t-Student test. The coefficient of correlation between the D0-values and
D1-values is 0.9623.
and holds for H =< 0.7. The coefficient of correlation R =
−0.911.
The second one is given by Equation (11)
λ = 1.1625− 0.5224H (11)
and holds for 0.7 < H < 0.9. The coefficient of correlation
R = −0.650.
The third one is given by Equation (12)
λ = 1.7503− 1.199H (12)
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FIGURE 3 | Two dimensional scatter plots showing all prostate carcinomas of the test set stratified according to a number of relationships between
the parameters: (A) (D0, LFD), (B) (D1, H), (C) (D0, λ), and (D) (H, λ). Differences between the complexity classes defined by the D0 or the D1 are statistically
significant at p < 0.0001 (Table 3). (A) The LFD divides the complexity classes into the five subsets (clusters 1–5 are marked by the numbers; compare Figure 4A).
Those clusters contain carcinomas with different values of the LFD, and, therefore, with different intercellular connectivity. In particular, 10 carcinomas of the class C1
(black circles) and four carcinomas of the class C2 (red circles) compose a cluster two with the lowest values of both the D0 and the LFD (Figure 4A), and the lowest
aggressiveness. The values are close to those of benign prostatic hyperplasia. The cluster five represents high-grade carcinomas with the largest values of both the
D0 and the LFD, the largest complexity, and the largest tumor aggressiveness (red squares and blue diamonds). (B) The dimension D1 is as strong classifier as the
D0, and divides the set of prostate carcinomas in the same classes of equivalence. Although the values of the Shannon entropy H overlap between the classes, and,
therefore, cannot play a role of the independent classifier, they characterize the spatial distribution of cancer cell nuclei in each class unequivocally if coupled with the
D0 or D1-dimension. The coefficient of correlation for this relationship is 0.950. (C) The values of lacunarity λ overlap between the classes of equivalence; however, a
combination of this diversity measure with the D0 or D1-dimension allows the unequivocal classification of the underlying spatial distribution of cancer cell nuclei. The
coefficient of correlation for this relationship is −0.902. The statistical linearity of this relationship confirms in the independent way the existence of fractal structure in
the spatial distribution of cancer cell cell nuclei. (D) Neither the Shannon entropy H nor lacunarity λ are strong classifiers. The values overlap between the classes of
equivalence. A small subset of carcinomas of the class C7 overlaps with carcinomas of the class C5. This results from a lower number of cells in cellular infiltrates.
However, this relationship is tri-linear. The coefficients of correlation for this relationship are −0.911, −0.650, and −0.922 for H < 0.7, 0.7 < H < 0.9, and H > 0.9,
respectively. The existence of tri-linearity suggests that some kind of qualitative transitions occur in natural history of prostate cancer between the class C2 and C3 as
well as the class C5 and C6.
and holds forH > 0.9. The coefficient of correlation R = −0.901.
Those relationships characterize well only the spatial distribution
of cancer cell nuclei in prostate carcinomas with very low or
very high diversity as measured by the Shannon entropy. Prostate
carcinomas with intermediate diversity cannot be stratified with
sufficient accuracy (compare Figures 3D,4B). The values of the
pairs (H, λ) overlap for many cases that belong to different
classes of equivalence defined by the D0 or the D1 (Figure 3D).
Figure 3A shows that the spatial distributions of cancer cell
nuclei in many prostate carcinomas are unique as represented by
different values of the pair (D0, LFD) (Figure 3A). Those values
are not identical owing to multifractality. Simultaneously, many
of those carcinomas have the same or almost identical values of
the pair (D1,H) (Figure 3B) or (H, λ) (Figure 3D). Two different
fractal dimensions denote the existence of two different spatial
distributions of cell nuclei. However, if the difference is not large,
the Shannon entropyH or lacunarity λmay be identical owing to
variability in cell numbers or their clustering.
The Co-Application of the Complexity and
Diversity Measures in the Evaluation of the
Spatial Distribution of Cancer Cell Nuclei in
Prostate Carcinomas
The cluster analysis by the k-means algorithm shows that the
co-application of both complexity and diversity measures, D0
(D1), LFD, LCFD, H, and λ leads to a reduction of a number of
clusters from seven to three (Figure 4B). Since low grade prostate
carcinomas possess well-preserved glandular structure, the values
of all the above measures but λ are also low. The reduction of the
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FIGURE 4 | Results of cluster analysis for the test set of prostate
carcinomas with the dimensions D0 and LFD (A) (ANOVA p < 0.001,
FD0 45799, FLFD 31935) and the parameters D0, LFD, LCFD, H, λ (B)
(ANOVA p < 0.001, FD0 75800, FLFD 25289, FLCFD 13202, FH 7925, Fλ
16102). The increment of the number of parameters from two to five reduces a
number of clusters from seven to three. The objective analysis can identify in
that way carcinomas with low-, intermediate-, and high complexity of the
spatial distribution of cancer cell nuclei corresponding to low-, intermediate- or
high tumor aggressiveness. The following conditions can be defined: for D0 <
1.5820, LFD < 1.3, LCFD > 1.5, H < 0.7 and λ > 0.8, the class C1 or C2
contains low-complexity, low-grade carcinomas exclusively; for D0 > 1.6980,
LFD > 1.7644, LCFD > 1.7051, H > 0.9, and λ < 0.7, the class C6 or C7
contains high-complexity, high-grade carcinomas only.
number of clusters identifies some carcinomas of the complexity
classes C1 and C2 as elements of the first cluster with the lowest
values of those parameters, and, therefore, the lowest tumor
aggressiveness. Similarly, one can define the quantitative criteria
for carcinomas with the highest values of those parameters but λ,
and the highest aggressiveness.
The mean LFD values do not increase along the complexity
classes monotonically (see Figure 3A and Table 3). Rather, those
values increase along each stratum, that is, a subset composed
of the classes C1 and C2 or C3 and C4, or C5 and C6, or C7
(Table 3). The mean LFD values can be identical for carcinomas
of different complexity classes.
The cluster analysis indicates five such subsets of prostate
carcinomas characterized by the pair (D0, LFD), in which the D0
is a measure of the global spatial distribution of cancer cell nuclei
and the local fractal dimension LFD is a measure of intercellular
connectivity (see Figures 3A,4A).
In the first subset, characterized by the parameters D0
< 1.5820 and LFD < 1.35, fourteen prostate carcinomas
of the class C1 or C2 (low grade prostate carcinomas with
mean PSA < 6.1 ng/ml, standard deviation 1.2 ng/ml, pT1b,
pT1c, or pT2a, Gleason score 6, relatively homogeneous well-
preserved glandular structure with glands distributed in tissue
sparsely, without a clustering or crowding, none of those
patients developed recurrence or metastases, or died owing
to prostate cancer during the 5 years of follow-up) revealed
very high intercellular connectivity. Those features are reflected
by the value of the local connected fractal dimensions LCFD
close to 1.5 (the scatter plot not shown), low values of
entropy H < 0.7 and high values of lacunarity λ >
0.8 (compare Figures 3A–D). The low values of the fractal
dimensions indicate that both global and local complexity
in those carcinomas is low. In addition, the values of those
fractal dimensions are quite close to the values obtained for
benign prostatic hyperplasia (see Table 3). All those local
and global features of the spatial distribution of cancer cell
nuclei are associated with a low potential for growth and
aggressiveness.
The second subset is composed of the low risk
adenocarcinomas (mean PSA 8.3 ng/ml, standard deviation
2.6 ng/ml, Gleason score 6, pT1b, pT1c, or pT2a) stratified
also to the classes C1 or C2. However, the second subset
has the same values of the D0, D1, almost the same values
of entropy H < 0.78 as well as lacunarity λ > 0.78, and
1.300 < LFD < 1.750. The values of the first four parameters
denote that number of cells and their spatial configurations
between those two sets are comparable. However, the values
of the LFD indicate the existence of more advanced alterations
in intercellular connectivity among adenocarcinomas of the
second subset in spite of the preserved glandular structure,
and, therefore, denote a higher risk of progression. Those
LFD values denote very slow, yet active growth owing to
the lower intercellular connectivity, and, therefore, increased
probability of metastasizing in the course of time in comparison
with the first subset. Those cancer patients belong to a
“gray” zone, in which a follow-up without any additional
therapy may work fine for some cases of the lower classes of
complexity, such as C1, C2, or even for some intermediate-risk
cases of the class C3 and C4 having the low values of the
LFD.
The third and the fourth subset comprise intermediate risk
prostate cancers of the complexity class C3, C4, C5 (mean PSA
12.7 ng/ml, standard deviation 2.2 ng/ml, Gleason score 7 and 8,
pT2b-2c). In the third subset, there are carcinomas with 1.5820
< D0 < 1.6980 and the LFD < 1.8. Prostate carcinomas of the
fourth subset have the same values of the D0 as in the third
set, but the LFD > 1.8 (see Figure 3A) at 0.65 < H < 0.85,
and 0.7 < λ < 0.82 (Figures 3B,C). Surprisingly, there are two
adenocarcinomas of the complexity class C2 in that subset. Their
mean LFD value approximate the value of 1.9, that is typical of
prostate carcinomas without glandular structure and with the
increased potential to metastasize. In spite of the stratification
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to the low class of complexity owing to the D0-value, such
carcinomas with very low intercellular connectivity may have a
high metastatic potential.
The fifth subset comprises high risk prostate cancers (mean
PSA 24.3 ng/ml, standard deviation 3.1 ng/ml, Gleason score 9–
10, stage T3a, the largest ratio of prostate carcinoma related
death or metastasis formation within 5 years from the surgical
treatment 0.442) of the complexity class C6 or C7 with D0 >
1.6980 and the LFD > 1.8, H > 0.9, and λ < 0.7. The large
values of the D0 and H indicate a significantly increased cell
number owing to the intense cell proliferation and rapid growth.
Since images are covered almost completely by cancer cells, and
become almost symmetrical, the λ-values are low. The high
values of the LFD indicate the existence of a very low intercellular
connectivity. Cells fill up the entire available tissue space without
any clustering, and, therefore, have the largest potential for
metastasis formation.
DISCUSSION
The classes of equivalence defined by the cut-off values of the
global capacity dimension D0 reported previously (Waliszewski
et al., 2015) have been validated. The other measures but the D1
failed to define the same classes of equivalence. However, the co-
application of all the measures allowed the formulation of two
quantitative criteria identifying low or high aggressive prostate
carcinomas.
A novel, quantitative strategy for the evaluation of tumor
aggressiveness excludes the automated diagnosis of prostate
carcinoma. The complexity or diversity measures were not
able to discriminate between the spatial distribution of cell
nuclei in benign prostatic hyperplasia, a common lesion in
human prostate, and carcinomas with a well-preserved glandular
structure (see Table 3). This approach implies a necessity to
examine the entire prostate carefully, what does not seem to
be the case in the routine practice (True, 1994). Indeed, the
largest value of the fractal dimension D0 or D1 determines the
stratification of carcinomas into a given class of equivalence.
Results of this study suggest that the number of the subjective
Gleason grades of tumor aggressiveness could be decreased from
seven to three without a loss of clinically important information,
that is, to the low, intermediate, or high grade. The identical
reduction could be done for a number of the objective classes of
equivalence. Table 1 indicates that pathologists can distinguish
quite well between the relatively homogeneous patterns with
the Gleason score 3+3, 4+4, or 5+5 (see the reference set).
However, heterogeneous patterns defined as the Gleason score
3+4, 4+3, 4+5, or 5+4 were classified with much greater
inaccuracy (see the test set). The classes of equivalence defined by
the cut-off D0-values enable the quantitative evaluation of tumor
aggressiveness of borderline cases with mixed tissue architecture;
a frequent problem in pathology of prostate carcinoma (Dong
et al., 2012). It should be noticed that the discrepancy between the
subjective Gleason classification and the classification according
to complexity of the spatial distribution of cancer cell nuclei
was on average about 53% in this study; a value that is in the
range of the intra- and interobserver variability (McLean et al.,
1997; Allsbrook et al., 2001; Nguyen et al., 2004; van der Kwast
et al., 2010; McKenney et al., 2011; Netto et al., 2011; Dong et al.,
2012; Egevad et al., 2013; Scott Lucia et al., 2013; Berney et al.,
2014).
The classes of equivalence, i.e., the complexity classes defined
by the cut-off values of the D0 dimension (or the D1 dimension)
were validated by analyzing the test set of carcinomas with
sensitivity, specificity, and AUC equal 1.0 (Waliszewski et al.,
2015). This set was larger and independent from the set analyzed
in the previously published study (Waliszewski et al., 2015).
The values of the global capacity fractal dimension D0 are
identical with those previously reported (Waliszewski et al., 2015)
(see Tables 2, 3, Figure 3). Those two dimensions appear to
be the best classifiers of prostate carcinomas according to the
spatial distribution of cancer cell nuclei. There is a very good
correlation between the values of the D0 and the D1 (correlation
coefficient R = 0.962). Those results were to be expected
since both sets comprised different numbers of carcinomas
with the similar patterns of tumor growth. As expected, the
D1-values correlate very well with the values of the Shannon
entropy H; a diversity measure of both randomness in the
spatial distribution of cell nuclei and information content in
images of a given class (R = 0.950; see Figure 3B). There
also is some correlation between the values H and λ that
changes depending on the H intervals (compare Equations 10–
12). The λ values overlap between classes (see Figure 3D),
and, therefore, cannot be applied for stratification as the
independent classifier. The overlapping results from the non-
bijective relationship between some configurations of cell nuclei
and the measures applied (Waliszewski et al., 2015). In particular,
two borderline spatial distributions of cancer cell nuclei may
have identical values of the complexity measures, but different
values of the diversity measures. In spite of that weakness, the
diversity measures help to identify carcinomas with low or high
diversity corresponding to carcinomas with the low or high
grade (see Figures 3B,C). Each of those measures characterizes
quantitatively different aspects of the spatial distribution of
cancer cell nuclei in images of prostate carcinomas. While
the D0 or the D1 enables the stratification of carcinomas into
the seven classes of equivalence, that remain unchanged if
the LFD, the LCFD, the Shannon entropy H or λ are added
to the class characteristics (see Figure 3), the co-application
of all the above-studied measures allows the stratification of
the same carcinomas into just three distinct clusters with low
tumor aggressiveness (class C1, C2, and some carcinomas of
the class C3), intermediate one (some carcinomas of the class
C3, C4, and C5) or high one (class C6 and C7) (compare
Figure 4). The appropriate quantitative criteria are defined in
the Sections Results: A Relationship between the Global Capacity
Dimension D0 and Lacunarity λ or the Global Information
Dimension D1 and Entropy H or is Linear; The Co-Application
of the Complexity and Diversity Measures in the Evaluation
of the Spatial Distribution of Cancer Cell Nuclei in Prostate
Carcinomas.
The presented data indicate some change in intercellular
connectivity at the interface between classes C2 and C3 as
well as C5 and C6 as measured by the LFD; a complexity
Frontiers in Physiology | www.frontiersin.org 12 February 2016 | Volume 7 | Article 34
Waliszewski Classes of Equivalence and Tumor Aggressiveness
measure of cellular connectivity, that is, a measure of strength
of intercellular interactions (Table 3, Figure 3A). This change
can also be seen in the scatter plot (H, λ) (Figure 3D). The
relationship between the Shannon entropy H and lacunarity λ; a
diversity measure of cell clustering also changes at the interface
between the above-mentioned classes and depends on the H-
values (R = − 0.911 for H <0.7, R = −0.650 for 0.7 <
H < 0.9, and − 0.901 for H > 0.9). Those changes correspond
with the enhanced dynamics of tumor growth at the interface
between low and intermediate risk cancers as well as intermediate
and high risk cancers. It is possible that all those changes result
from some genetic instability that gains influence on growth
dynamics at some specific check-points in natural history of
prostate cancer. Second, results of the analysis point out that
prostate carcinomas with the spatial distributions of cancer cell
nuclei holding the conditionsD0 < 1.5820, LFD< 1.3, and LCFD
> 1.5 are true low grade carcinomas. Those carcinomas possess a
well-preserved, relatively homogeneous glandular structure that
resembles the structure of the normal prostatic glands. There is
some intermediate cell clustering at the low values of the LFD
and, therefore, high intercellular connectivity in cell populations
of those adenocarcinomas (Figure 3A). Hence, there is no high
growth potential in those cellular populations. If D0 > 1.6980,
LFD > 1.7644, and LCFD > 1.7051, then tumor aggressiveness
is large. Cancer cells infiltrate the entire available tissue space,
have low intercellular connectivity, do not interact each other,
and compose passively multiple cell clusters; the overcrowding
effect. This constellation of dimensions indicates the existence
of a large growth potential in a cellular population. The cases
with intermediate conditions compose a gray zone. Some of
those carcinomas may do well under follow-up, especially those
with the lower values of the LFD and LCFD. The other cases
will certainly require some kind of therapy in the course of
time. It is interesting, however, that there is no carcinoma with
the low values of both local fractal dimensions. If the LFD
increases, then intercellular connectivity decreases, and cells lose
their capability to interact with each other. Therefore, cells in
some carcinomas including those of the class C1, C2, C3, and
C4 do not create clusters (the lower values of the LCFD), while
many others still do (the larger values of the LCFD). The loss of
capability for cell clustering at low values of the LCFD may also
denote both the increased growth potential and risk of metastasis
formation.
The increasing values of theD0 dimension denote that cellular
proliferation in a given carcinoma is very extensive, and more
and more cancer cells fill up the available tissue space. If cancer
cell gather in some kind of glands or gland-like objects, the D0-
values are lower than if there dominate cellular infiltrates in the
image (compare the values of the D0 for the classes C1, C2 or
C3 with those for the classes C6 or C7 in Table 3). The larger
is the value of the D0 the higher is the complexity class and
the corresponding subjective grade. The higher is the complexity
class the higher is a number of cancer cells present in the image
of prostate carcinoma. Cancer cells lose in the course of natural
tumor evolution their cluster organization in a form of glands
(high values of the D1, the LFD, and the LCFD and low values
of λ), become more randomly distributed (high values of H),
and reveal lower connectivity (high values of the LFD and the
LFCD) (compare Figures 3A–D). The risk of local progression
or metastasis formation is increased in those spatial distributions
of cancer cell nuclei.
The existence of both the global and local fractal dimensions
for a given spatial distribution of cancer cell nuclei implies
that that spatial distribution underlies a scale-dependent power
law. The existence of the power law means that the spatial
distribution of cancer cell nuclei undergoes somehow ordered
rather than utterly random changes in the course of natural
history of the prostatic tumorigenesis. That order of events
appears to comprise the gradual loss of intercellular connectivity
in carcinomas of the higher complexity classes (see Table 3 and
Figure 3). This may occur owing to the loss of expression of
adhesion molecules or some other molecules with biologically
important functions leading to alterations of intercellular
interactions (Busch et al., 2002; Huang et al., 2009; Mathieu
et al., 2013; Schrecengost and Knudsen, 2013). For the majority
of carcinomas, the values of both the global and local fractal
dimension are not identical (see Table 3 and Figure 3). That
difference between the values of the global and local fractal
dimensions indicates the existence of multifractals in the spatial
distributions of cancer cell nuclei, that is, fractals that scale
with multiple scaling rules and hold the condition D0 > D1
> D2 (reviewed in Lopes and Betrouni, 2009). Multifractality
suggests that the final spatial distribution of cancer cells
depends on both a variety of molecular events and long-
range phenomena such as diffusion. The interactions may
occur at different levels of the hierarchical tissue dynamic
system (Waliszewski, 1997; Waliszewski et al., 1998, 2001).
Those complex phenomena compose a new world to be
explored.
Two diversity measures CV-LFD and CV-LCDF do not
play a role in the stratification process (see Table 3). Those
diversity measures apply to differences in measurements of the
local fractal dimensions within each complexity class (Page,
2011). There is no monotonic increment of the values of those
parameters that might enable the stratification process. However,
entropy, the other diversity measure, appears to be useful in
the additional characterization of the spatial distribution of cell
nuclei (Equations 2, 4, 5 and Figure 3B). Even though the local
fractal dimensions in each complexity class that relate to single
cancer cell nuclei are not diverse, cancer cells as a population
form diverse dynamic spatial structures of the higher order,
such as cell clusters (see Figure 3A). Those cell clusters can
be characterized locally by the values of the local connected
fractal dimension, entropy, and lacunarity. In addition, the
LFD identifies cells with the lowest intercellular connectivity,
and, therefore, having the maximal metastatic potential (see
Figure 3A; Waliszewski, 1997, 2005, 2009, 2013; Waliszewski
et al., 1998, 2001; Waliszewski and Konarski, 2001). Computer
simulations of a model considering the evolution of cooperation
in a spatial setting obtained by Nowak and May show clearly
the existence of a relationship between emergent diversity and
complexity (Nowak and May, 1992, 1993). The existence of that
relationship in prostate carcinomas can be seen in equation 5 and
Figure 3B.
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To summarize, the following findings must be reiterated.
First, the classes of equivalence for prostate carcinomas by the
cut-off D0-values were validated. Second, no other measure
studied but the D1 can define the same classes of equivalence.
Third, carcinomas with low complexity of the spatial distribution
of cancer cell nuclei reveal low biological aggressiveness, and
vice versa. Some pairs of the parameters (D0, LFD), (D0, H)
or (D0, λ) or (D1, LFD), (D1, H) or (D1, λ) characterize
well complexity of the spatial distribution of cancer cell nuclei
in each class of equivalence. The tri-linear course of the
relationship (H, λ) suggests that among carcinomas of the
classes C2 and C3 as well as C5 and C6 occurs some kind
of a qualitative transition that implicates changes in tumor
aggressiveness. Fourth, the co-application of all complexity and
diversity measures reduces a number of clusters, but still enables
the identification of carcinomas with low or high complexity
of the spatial distribution of cancer cell nuclei. Those findings
suggest the number of both the subjective Gleason grades and the
objective classes of equivalence could be decreased from seven to
three.
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